 |
alpha-1 proteinase inhibitor (human) |
|---|---|
| Trade Name | Glassia |
| Orphan Indication | Patients with recent onset (<15 years)with Type 1A diabetes mellitus with residual beta-cell function |
| USA Market Approval | USA |
| USA Designation Date | 2011-07-28 00:00:00 |
| Sponsor | Kamada, Ltd.;2 Holtzman Street;Rehovot |
